Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of Oaktree Acquisition Corp. III Life Sciences from Q2 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Oaktree Acquisition Corp. III Life Sciences quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q2 2024 to Q3 2025.
  • Oaktree Acquisition Corp. III Life Sciences Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Sep 2025 was $1.33M.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)

Oaktree Acquisition Corp. III Life Sciences Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.33M +$1.33M 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $1.39M +$1.39M 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $1.28M 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $1.36M 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $0 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $0 27 Jun 2024 10-Q 13 Nov 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.